Skip to main content
Clinical Trials/ISRCTN11665378
ISRCTN11665378
Active, not recruiting
未知

The utility of frequency-modulated electromagnetic neural stimulation as a third-line treatment in patients with painful diabetes-related peripheral neuropathy: a randomised controlled trial

niversity of Birmingham0 sites356 target enrollmentJanuary 16, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Painful diabetes-related peripheral neuropathy
Sponsor
niversity of Birmingham
Enrollment
356
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 16, 2023
End Date
April 30, 2025
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=18 years
  • 2\. Neuropathic pain affecting both feet for \=3 months or taking pain medication for neuropathic pain for \=3 months
  • 3\. Mean pain score \=4 on the daily NRS for 1 week prior to randomisation
  • 4\. Douleur Neuropathique 4 (DN\-4\) questionnaire score \=4/10 at screening to confirm the diagnosis of bilateral distal symmetrical neuropathic pain
  • 5\. Diabetes\-related neuropathy based on the Michigan Neuropathy Screening Instrument (MNSI) (MNSI questionnaire scored \=7 or examination scored \>2\)
  • 6\. HbA1c \<108 mmol/mol or 12% (within the last 2 months)
  • 7\. Have tried at least two drugs from two different classes for PDPN
  • 8\. Willing and able to comply with the study schedule and be available for the treatment duration
  • 9\. Able to give written informed consent

Exclusion Criteria

  • 1\. Non\-diabetic neuropathies
  • 2\. Currently using TENS for PDPN
  • 3\. History of epilepsy
  • 4\. Other painful medical conditions where the pain is significantly more severe than their PDPN pain (patients will not be excluded if the pain is transient in nature)
  • 5\. Major amputations of the lower limbs
  • 6\. Active diabetic foot ulcers
  • 7\. Diagnosed malignancy
  • 8\. Pacemakers, defibrillator or neurostimulator
  • 9\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials